The University of Chicago Header Logo

Connection

Pankti Reid to Antirheumatic Agents

Back to Details
This is a "connection" page, showing publications Pankti Reid has written about Antirheumatic Agents.
Pankti Reid
Connection Strength
0.876
Antirheumatic Agents
  1. Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk. JAMA Netw Open. 2024 Nov 04; 7(11):e2446336.
    View in: PubMed
    Score: 0.235
  2. JAK inhibitors and black box warnings: what is the future for JAK inhibitors? Expert Rev Clin Immunol. 2023 Jul-Dec; 19(11):1385-1397.
    View in: PubMed
    Score: 0.216
  3. Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071.
    View in: PubMed
    Score: 0.215
  4. Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Ann Rheum Dis. 2023 07; 82(7):920-926.
    View in: PubMed
    Score: 0.210
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.